No Detail Found!

Efficacy of Isotretinoin in Treating Fungal Infections: A Systematic Review

Author(s)
Nouf Almagushi College of Medicine, King Saud Bin Abdulaziz University for Health and Sciences,Riyadh,Saudi Arabia
Remah Alzayyat Department of Dermatology, Ministry of Health,Riyadh,Saudi Arabia
Ajlan Alajlani General Practitioner, General Directorate of Prisons' Health,Riyadh,Saudi Arabia
Ashjan Alheggi Department of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU),Riyadh,Saudi Arabia
Majed Aleissa Department of Dermatology, National Guard Hospital,Riyadh,Saudi Arabia
Abstract
Objective: This systematic review evaluates the effectiveness of oral isotretinoin, either as monotherapy or in combination with antifungal agents, in treating fungal skin infections. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) standards were adhered to in drafting the systematic review. An extensive search was performed in the following databases covering the last decade from January 2015 to December 2024: PubMed, Scopus, Web of Science and Google Scholar. The selection of eligible studies adhered to the PICOS criteria (Population, Intervention, Comparator, Outcome and Study design). Due to substantial heterogeneity in study designs, interventions and outcome measures, a quantitative meta-analysis was not feasible and findings were synthesized narratively. Results: Two hundred forty-nine articles concerning the use of isotretinoin for fungal infections were identified. Titles and abstracts of 152 studies were evaluated, resulting in 54 studies deemed eligible for full-text evaluation. Finally, this review considered 16 studies evaluating isotretinoin regimens ranging from low-dose schedules (10-20 mg/day) to weight-based dosing up to 0.5 mg/kg/day. Four studies were on dermatophytosis, three on seborrhoeic dermatitis and two on pityriasis versicolor and tinea, with isolated reports on chromoblastomycosis and mycosis fungoides. The most consistent evidence of clinical benefit was observed in recurrent dermatophytosis and seborrhoeic dermatitis, especially when isotretinoin was used as an adjunct to the standard therapy. Out of the six studies evaluated using the ROBINS-I tool, three studies exhibited a low RoB and three other studies demonstrated a serious RoB. The RoB 2.0 tool revealed that all the assessed RCTs exhibited high RoB, except for one study that raised some concerns. Conclusion: Isotretinoin has potential in the adjuvant treatment of fungal infections especially recurrent dermatophytosis but is more of a supportive than a standalone therapy. Clinical Relevance: Isotretinoin may be a promising adjunctive therapy, especially in recurrent dermatophytosis and should be further investigated as a way to improve treatment outcomes and reduce disease recurrence.
Publication Details
Page(s) 174-185
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 6, Year: 2026

Request the full text from PASTIC

Keywords
tinea, Isotretinoin, Antifungal Drugs, Fungal Diseases, Mycosis
References
Sahoo A.K.,Mahajan R. . .Management of Tinea Corporis, Tinea Cruris and Tinea Pedis: A Comprehensive Review. Indian Dermatology Online Journal, 7(2016) : 17-5178.
Singh S.K. . .Eficacy of Terbinain e and Itraconazole in Different Doses and in Combination in the Treatment of Tinea Infection: A Randomized Controlled Parallel Group Open Labeled Trial with Clinico-Mycological Correlation. Indian Journal of Dermatology, 548(2020) : 19-289.
Khattab F. . .. Update in the Treatment of Recalcitrant Dermatophytosis.” Annals of the Romanian Society for Cell Biology, 25(2021) : 16012-16017.
Ardeshna K.P. . .Successful Treatment of Recurrent Dermatophytosis with Isotretinoin and Itraconazole. Indian Journal of Dermatology, : .
Cosio T. .2021 .Retinoids in Fungal Infections: From Bench to Bedside. , 14(10) : .
Paichitrojjana A.,Paichitrojjana A. .2023 .Oral Isotretinoin and Its Uses in Dermatology: A Review.” Drug Design, Development and Therapy. , 17 : 2573-2591.
Kowalski C.H. .2020 .. Fungal Bioilm Architecture Produces Hypoxic Microenvironments That Drive Antifungal Resistance.” Proceedings of the National Academy of Sciences of the United States of America, 117(36) : 22473-22483.
Tan F. .2019 .Bactericidal and Anti-Bioilm Activity of the Retinoid Compound CD437 Against Enterococcus faecalis. , 02301 : .
Seebacher C. .2008 .. Updates on the Epidemiology of Dermatophyte Infections.” Mycopathologia, 166(6) : 335-352.
Page M.J. .2021 .. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews.” BMJ, 372 : .
Sterne J.A. .2016 .ROBINS-I: A Tool for Assessing Risk of Bias in Non-Randomised Studies of Interventions. ” BMJ, 355 : .
Higgins J.,updated August 2023 .2023 .Chapter 8: Assessing Risk of Bias in a Randomized Trial.” Cochrane Handbook for Systematic Reviews of Interventions, version 6. , : .
Veasey J.V. .2023 .. Oral Isotretinoin for the Treatment of Chronic Pityriasis Versicolor: Case Report and Literature Review.” Anais Brasileiros de Dermatologia, 08(2024) : 639-642.
Priyadarshi D. . .Safety and Eficacy of Oral Itraconazole versus Combination with Oral Isotretinoin in Supericial Dermatophytosis: A Randomised Clinical Trial. ” Journal of Clinical and Diagnostic Research, 17(2023) : WC01-WC05.
Yanfei Z. . .Eficacy and Safety of Oral Isotretinoin in the Treatment of Moderate to Severe Seborrheic Dermatitis: A Retrospective Study. International Journal of Dermatology, 62(2023) : 759-763.
Alhamdi D.K.,K.I. Alhamdi. D.K. .2022 .Eficacy and Safety of Adding Low-Dose Isotretinoin to Itraconazole in the Treatment of Chronic Recurrent Dermatophytosis among Sample of Iraqi Patients: An Open-Labelled Therapeutic Clinical Comparative Study. Indian Journal of Dermatology, 332(5) : 22.
Khattab F. .2022 .Voriconazole Is Superior to Combined Itraconazole/Isotretinoin Therapy and Itraconazole Monotherapy in Recalcitrant Dermatophytosis. ” Mycoses, 65(12) : 1194-1201.
Lan Y. . .. Retinoid Combined with Photodynamic Therapy against Hyperkeratotic Chromoblastomycosis: A Case Report and Literature Review.” Mycoses, 64(2021) : 18-23.
Naseemullah .2021 .Eficacy of Itraconazole vs Itraconazole Plus Isotretinoin in Treatment of Chronic Tinea. Pakistan Journal of Medical & Health Sciences, 15(10) : 3316-3318.
Verma K.K. . .Oral Isotretinoin Combined with Oral Terbinaine Versus Oral Terbinaine Alone to Treat Recurrent Dermatophytosis: An Open-Label Randomised Clinical Trial. Indian Dermatology Online Journal, 167(2021) : 21-825.
Taşlıdere N. .2020 .Effects of Narrow-Band UVB Alone and in Combination with Isotretinoin on Apoptosis and Its Clinical Implications in Early Stage Mycosis Fungoides. ” Journal of the Turkish Academy of Dermatology, 36854(2020) : 6-11.
Kaushik K.,Cruris Tinea .2019 .To Compare Eficacy of Oral Isotretinoin and Itraconazole Combination with Salicylic Acid 30% Chemical Peel for Tinea Corporis. International Journal of Current Research, 58(12) : 8936-8939.
Rahman M.H.,Dermatophytosis Recalcitrant . .Role of Itraconazole Pulse Therapy with Adjuvant Isotretinoin in Treating Recurrent. Gulf Journal of Dermatology and Venereology, 26(2019) : 11-14.
Arora R.,Solanki A. . .Comparative Eficacy of Monotherapy of Oral Itraconazole and Oral Itraconazole with Isotretinoin in Chronic and/or Resistant Supericial Dermatophytosis. Journal of Research, 7(2018) : 9-11.
Kamamoto C.S.L.,Trial Therapeutic,Dermato-Endocrinology Therapeutic .2017 .Cutaneous Fungal Microbiome: Malassezia Yeasts in Seborrheic Dermatitis Scalp in a Randomized, Comparative. , 1361573(1) : .
Meran A.D.,Saeed M.Y. . .Eficacy and Safety of Low Dose Oral Isotretinoin in Comparison with Oral Itraconazole in the Treatment of Seborrheic Dermatitis among Patients Attending Erbil Dermatology Teaching Center in Erbil City. Zanco Journal of Medical Sciences, 22(2018) : 420-426.
Yazici S.,Baskan B.E.,Saricaoglu H. .2018 .“Long-Term Remission of Recurrent Pityriasis Versicolor with ShortTerm Systemic Isotretinoin Therapy. ” Journal of Dermatology & Cosmetology, 02(2018) : 94-95.
de Souza Lea C. . .Low-Dose Oral Isotretinoin for Moderate to Severe Seborrhea and Seborrheic Dermatitis: A Randomized Comparative Trial. International Journal of Dermatology, 56(2017) : 80-85.
Rajagopalan M. .2018 .Expert Consensus on the Management of Dermatophytosis in India (ECTODERM India). ” BMC Dermatology, 18(1) : .
Monod M. .2019 .Antifungal Resistance in Dermatophytes: Emerging Problem and Challenge for the Medical Community. ” Journal de Mycologie Médicale, 100913(2019) : 283-284.
Majid I. . .Relapse after Oral Terbinaine Therapy in Dermatophytosis: A Clinical and Mycological Study. Indian Journal of Dermatology, 61(2016) : 190120-5154.
Tsuboi R. .1989 .Isolation of a Keratinolytic Proteinase from Trichophyton mentagrophytes with Enzymatic Activity at Acidic pH. ” Infection and Immunity, 57(11) : 3479-3483.
Thune P. . .The Water Barrier Function of the Skin in Relation to the Water Content of Stratum Corneum, pH and Skin Lipids. The Effect of Alkaline Soap and Syndet on Dry Skin in Elderly, Non-Atopic Patients. ” Acta DermatoVenereologica, 68(1988) : 277-283.
Prabhala R.H. . .Enhancement of the Expression of Activation Markers on Human Peripheral Blood Mononuclear Cells by In Vitro Culture with Retinoids and Carotenoids. ” Journal of Leukocyte Biology, 45(1989) : 249-254.
Martinez-Rossi N.M. .2008 .. Antifungal Resistance Mechanisms in Dermatophytes.” Mycopathologia, 166(6) : 008-383.
Ogawa H. . .Dermatophytes and Host Defence in Cutaneous Mycoses. Medical Mycology, 36(1998) : 166-173.
Kraus S.J. . .. Stress, Acne and Skin Surface Free Fatty Acids.” Psychosomatic Medicine, 32(1970) : 00006842-508.
Cowley N.C. .1990 .The Permissive Effect of Sebum in Seborrhoeic Dermatitis: An Explanation of the Rash in Neurological Disorders. British Journal of Dermatology, 122(1990) : 2133-76.
Friedman S.J. . .Treatment with Isotretinoin. ” Journal of the American Academy of Dermatology, 9622(87) : 80117-2.
Layton A.M. .1993 .Isotretinoin for Acne Vulgaris-10 Years Later: A Safe and Successful Treatment. British Journal of Dermatology, 129(1993) : 2133-296.
Mandekou-Lefaki I. .2003 .Low-Dose Schema of Isotretinoin in Acne Vulgaris. International Journal of Clinical Pharmacology Research, 23(3) : 41-46.
Bartell H. . .Tinea Versicolor Clearance with Oral Isotretinoin Therapy. ” Journal of Drugs in Dermatology, 5(2006) : 74-75.
Abraham S.,Piguet V. . .. “An Unusual Presentation of Malassezia Dermatosis.” Dermatology, 212(2006) : 4-6.
King A. .2023 .Isotretinoin for the Management of Moderate-to-Severe Seborrheic Dermatitis: A Systematic Review. ” Journal of the American Academy of Dermatology, 07(2023) : 1063-1066.
Barzilai A. . .Seborrheic Dermatitis-Like Eruption in Patients Taking Isotretinoin Therapy for Acne: Retrospective Study of Five Patients. American Journal of Clinical Dermatology, 9(2008) : 00128071-261.
Srivastava A,Kothiwala S.K. . .Isotretinoin May Affect Pharmacokinetics of Itraconazole in the Skin: Is It Rational to Combine Both for the Treatment of Dermatophytosis?”. Indian Journal of Dermatology, Venereology and Leprology, 83(2017) : 194292-6323.
Brzezinski P. .2017 .Adverse Effects of Isotretinoin: A Large, Retrospective Review. Dermatologic Therapy, 30(4) : .
Kapała J. .2022 .Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis. International Journal of Environmental Research and Public Health, 19(11) : .
Rivillas J.A. .2020 .. Myositis Induced by Isotretinoin: A Case Report and Literature Review.” American Journal of Case Reports, 21 : .
0

Citations

0

Downloads

20

Views